プラウラ出血と肺腫を呈する猫における耐火性閉塞性心不全までの時間
K M Buchanan1, R C Fries1, S Kadotani1
1Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, 1008 W Hazelwood Dr, Urbana, IL 61802, USA.
まとめ
心不全 (CHF) の猫は,肺腫の患者と比較して,短期間生存し,耐火性CHFへの進行が速くなります.
科学分野:
- 獣医心臓科
- 猫医学
- 心血管研究
背景:
- 猫の左側閉塞性心不全 (CHF) は,通常,胞流出または肺腫として表れます.
- 猫の心臓の治療には,これらの異なる症状の予後的な影響を理解することが重要です.
研究 の 目的:
- 重症性閉塞性心不全 (CHF) と生存期間を比較する.
- 様々な心筋病と診断された猫の予後要因を特定する.
主な方法:
- 2013年から2022年の間にCHFと診断された125匹の猫を遡って評価した.
- 猫は,プレウラ出血 (n=73) または肺腫 (n=52) の主要症状に基づいて分類された.
- 耐火性CHFは,フロセミドの特定の投与量またはトルセミドの開始量によって定義され,生存時間および耐火性CHFまでの時間が記録されました.
主要な成果:
- 肺流出の猫は,肺腫の猫 (234日) に比べて,生存期間の中央値が著しく短かった (155日).
- 肺腫 (133日) と比較して,肺腫 (44日) が発症した猫では,耐火性心筋梗塞に至るまでの平均時間は著しく短かった.
- 多変量分析では,胸膜流出は,耐火性心筋梗塞 (HR: 2.26) と生存時間 (HR: 1.87) の減少の両方の有意な予測因子でした.
結論:
- 肺性硬化症の猫の胞流出は,生存期間が短く,耐性疾患への進行が早くなるなど,予後が悪い.
- これらの発見は,ネコのCHFの予後評価において,胞流出と肺腫を区別することの重要性を強調しています.
- 研究の限界には,標準化されていない治療勧告と不完全な液体分析データが含まれていた.
関連する概念動画
01:28Pleural Effusion II: Symptoms and Management
265
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
265
01:17Pericarditis III: Medical Management
26
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
26
01:25Pleural Effusion I: Introduction
1.8K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.8K
01:26Heart Failure III: Clinical Manifestations
42
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
42
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21